ENTX & OPK Stock May Gain Following Positive PK/PD Research Data [Yahoo! Finance]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Yahoo! Finance
ongoing collaborative research combining a proprietary long-acting oxyntomodulin (OXM) analog developed by OPKO and Entera's proprietary N-Tab technology. The program is focused on developing the first oral dual agonist GLP-1/glucagon peptide as a potential once-daily treatment for patients with obesity and metabolic and fibrotic disorders. OXM is a naturally occurring peptide hormone found in the small intestine that acts to suppress appetite and induce weight loss. Likely Trend of ENTX & OPK Stocks Following the News Following the announcement, shares of ENTX moved south 1.5% and closed at $1.93, while shares of OPK closed nearly flat at $1.48 on Wednesday. Per a report by Grand View Research, the global weight management market size was valued at $142.58 billion in 2022 and is expected to witness a CAGR of 9.94% from 2023 to 2030. Accordingly, we anticipate the stocks to gain on investors' optimism around the positive research results focused on treatment for patients with
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024PR Newswire
- Quest Diagnostics Stock Gains From New Offerings, Customer Wins [Yahoo! Finance]Yahoo! Finance
- Here's Why Quest Diagnostics (DGX) is a Strong Value Stock [Yahoo! Finance]Yahoo! Finance
- DGX Stock to Benefit From New Partnership With Sentara Health Plans [Yahoo! Finance]Yahoo! Finance
- Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 7/23/24 - Beat
DGX
Sec Filings
- 9/26/24 - Form 4
- 9/3/24 - Form 4
- 8/29/24 - Form 4
- DGX's page on the SEC website